Ascendis Pharma A/S
ASND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612042
In the last 90 days, Ascendis Pharma A/S insiders filed 1 open-market purchase and 2 sales; 315 institutions reported holding it in 13F filings for Q2 2026, worth $17.8B in total; no superinvestor holds it.
SEC filings
10-K, 10-Q, 8-K, 20-F and 40-F reports Ascendis Pharma A/S filed with the SEC, newest first.
Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.
| Filed | Form | 8-K items | Period | Document | Filing index |
|---|---|---|---|---|---|
| Feb 11, 2026 | 20-F | – | Dec 31, 2025 | SEC | Index |
| Feb 12, 2025 | 20-F | – | Dec 31, 2024 | SEC | Index |
| Feb 7, 2024 | 20-F | – | Dec 31, 2023 | SEC | Index |
| Feb 16, 2023 | 20-F | – | Dec 31, 2022 | SEC | Index |
| Mar 2, 2022 | 20-F | – | Dec 31, 2021 | SEC | Index |
| Mar 10, 2021 | 20-F | – | Dec 31, 2020 | SEC | Index |
| Apr 3, 2020 | 20-F | – | Dec 31, 2019 | SEC | Index |
| Apr 3, 2019 | 20-F | – | Dec 31, 2018 | SEC | Index |
| Mar 28, 2018 | 20-F | – | Dec 31, 2017 | SEC | Index |
| Mar 22, 2017 | 20-F | – | Dec 31, 2016 | SEC | Index |
| Apr 15, 2016 | 20-F | – | Dec 31, 2015 | SEC | Index |
| Mar 26, 2015 | 20-F | – | Dec 31, 2014 | SEC | Index |